Susquehanna International Group, LLP Crispr Therapeutics Ag Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Susquehanna International Group, LLP holds 260,821 shares of CRSP stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

260,821

Previous 73,238 256.13%

Holding current value

$11.9 Million

Previous $4.99 Million 182.23%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$51.17 - $68.18 $9.6 Million - $12.8 Million	187,583 Added 256.13%	260,821 $14.1 Million
Q1 2024 May 07, 2024	SELL	$60.67 - $89.12 $8.73 Million - $12.8 Million	-143,858 Reduced 66.26%	73,238 $4.99 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $1.33 Million - $2.49 Million	34,531 Added 18.91%	217,096 $13.6 Million
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $855,419 - $1.11 Million	18,846 Added 11.51%	182,565 $8.29 Million
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $5.78 Million - $9.02 Million	-133,070 Reduced 44.84%	163,719 $9.19 Million
Q1 2023 May 16, 2023	BUY	$41.0 - $56.12 $8.81 Million - $12.1 Million	214,882 Added 262.35%	296,789 $13.4 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $1.57 Million - $2.63 Million	40,084 Added 95.84%	81,907 $3.33 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $305,866 - $419,402	5,006 Added 13.6%	41,823 $2.73 Million
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $8.99 Million - $15.4 Million	-207,914 Reduced 84.96%	36,817 $2.24 Million
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $17.6 Million - $26.3 Million	-331,716 Reduced 57.54%	244,731 $15.4 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $12.1 Million - $19.3 Million	173,303 Added 42.99%	576,447 $43.7 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $5.62 Million - $7.98 Million	50,971 Added 14.47%	403,144 $45.1 Million
Q2 2021 Aug 11, 2021	SELL	$100.84 - $161.89 $9.75 Million - $15.7 Million	-96,716 Reduced 21.55%	352,173 $57 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $31.3 Million - $59.4 Million	282,629 Added 169.99%	448,889 $54.7 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $6.96 Million - $15.1 Million	87,299 Added 110.56%	166,260 $25.5 Million
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $8.25 Million - $10.6 Million	-105,081 Reduced 57.1%	78,961 $6.6 Million
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $768,267 - $1.52 Million	-19,955 Reduced 9.78%	184,042 $13.5 Million
Q1 2020 May 15, 2020	BUY	$33.68 - $62.53 $215,417 - $399,941	6,396 Added 3.24%	203,997 $8.65 Million
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $2.77 Million - $5.53 Million	75,631 Added 62.01%	197,601 $12 Million
Q3 2019 Nov 14, 2019	SELL	$40.99 - $52.56 $2.48 Million - $3.18 Million	-60,477 Reduced 33.15%	121,970 $5 Million
Q2 2019 Aug 16, 2019	BUY	$35.45 - $48.2 $118,367 - $160,939	3,339 Added 1.86%	182,447 $8.59 Million
Q2 2019 Aug 14, 2019	SELL	$35.45 - $48.2 $444,897 - $604,910	-12,550 Reduced 6.55%	179,108 $8.44 Million
Q1 2019 May 15, 2019	SELL	$28.02 - $40.87 $374,263 - $545,900	-13,357 Reduced 6.52%	191,658 $6.85 Million
Q4 2018 Feb 14, 2019	SELL	$22.73 - $42.34 $3 Million - $5.59 Million	-131,945 Reduced 39.16%	205,015 $5.86 Million
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $6.52 Million - $9.66 Million	147,022 Added 77.41%	336,960 $14.9 Million
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $1.4 Million - $2.41 Million	32,748 Added 20.83%	189,938 $11.2 Million
Q1 2018 May 15, 2018	BUY	$23.52 - $58.17 $2.98 Million - $7.36 Million	126,589 Added 413.68%	157,190 $7.19 Million
Q4 2017 Feb 14, 2018	BUY	$16.95 - $23.48 $106,412 - $147,407	6,278 Added 25.81%	30,601 $719,000
Q3 2017 Nov 14, 2017	BUY	$16.75 - $20.66 $407,410 - $502,513	24,323	24,323 $435,000

Others Institutions Holding CRSP

# of Institutions

523

Shares Held

58M

Call Options Held

1.73M

Put Options Held

1.84M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.56B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Crispr Therapeutics Ag Transaction History